Prevention of invasive cervical cancer in the United States: Past, present, and future

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 9, 2012, Pages 1402-1408

  Pierce Campbell, Christine M ^a   Menezes, Lynette J ^b   Paskett, Electra D ^c   Giuliano, Anna R ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; WART VIRUS VACCINE;

CANCER GRADING; CANCER INVASION; ETHNIC DIFFERENCE; HEALTH CARE AVAILABILITY; HEALTH CARE DISPARITY; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HIGH RISK PATIENT; HUMAN; INVASIVE CERVICAL CANCER; MEDICAL PRACTICE; PAPILLOMAVIRUS INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; UNITED STATES; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS; WOMEN'S HEALTH;

COST OF ILLNESS; FEMALE; HUMANS; PAPILLOMAVIRUS VACCINES; SOCIAL CLASS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 84866177088     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-1158     Document Type: Review

References (51)

1. American Cancer Society. Cancer facts & figures 2011. Atlanta, GA: American Cancer Society; 2011.
2. Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LA, Eheman C, et al. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 2011;103:714-36.
3. Scarinci IC, Garcia FA, Kobetz E, Partridge EE, Brandt HM, Bell MC, et al. Cervical cancer prevention: new tools and old barriers. Cancer 2010;116:2531-42.
4. Howlader N, Noone A, Krapcho M, Neyman N, Aminou R, Waldron W, et al. editors. SEER cancer statistics review, 1975-2008. Bethesda, MD: National Cancer Institute; 2011 [cited 2011 Nov 29]. Available from: http://seer.cancer.gov/ csr/1975-2008.
5. Patel NR, Rollison DE, Barnholtz-Sloan J, Mackinnon J, Green L, Giuliano AR. Racial and ethnic disparities in the incidence of invasive cervical cancer in Florida. Cancer 2009;115:3991-4000.
6. Watson M, Saraiya M, Benard V, Coughlin SS, Flowers L, Cokkinides V, et al. Burden of cervical cancer in the United States, 1998-2003. Cancer 2008;113:2855-64.
7. Leyden WA, Manos MM, Geiger AM, Weinmann S, Mouchawar J, Bischoff K, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst 2005;97:675-83.
8. Spence AR, Goggin P, Franco EL. Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med 2007;45:93-106.
9. Surveillance Research Program, National Cancer Institute. Fast Stats: An interactive tool for access to SEER cancer statistics [homepage on the Internet]. Bethesda, MD: National Cancer Institute [cited 2012 Jan 25]. Available from: http://seer.cancer.gov/faststats/.
10. Ohio Department of Health. Ohio Cancer Incidence Surveillance System, 2001-2005 [Internet]. Columbus, OH: Ohio Department of Health; 2010 [cited 2011 Sep 12]. Available from: http://www.odh.ohio.gov/healthstats/ocisshs/ci-surv1. aspx.
11. Newmann SJ, Garner EO. Social inequities along the cervical cancer continuum: a structured review. Cancer Causes Control 2005;16:63-70.
12. Nuno T, Castle PE, Harris R, Estrada A, Garcia F. Breast and cervical cancer screening utilization among Hispanic women living near the United States-Mexico border. J Womens Health (Larchmt) 2011;20:685-93.
13. Akers AY, Newmann SJ, Smith JS. Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States. Curr Probl Cancer 2007;31:157-81.
14. Johnson CE, Mues KE, Mayne SL, Kiblawi AN. Cervical cancer screening among immigrants and ethnic minorities: a systematic review using the health belief model. J Low Genit Tract Dis 2008;12:232-41.
15. Centers for Disease Control and Prevention. Behavioral risk factor surveillance system survey data [homepage on the Internet]. Atlanta, GA: Centers for Disease Control and Prevention; 2010 [cited 2011 Sep 12]. Available from: http://www.cdc.gov/brfss/.
16. Battaglia TA, Santana MC, Bak S, Gokhale M, Lash TL, Ash AS, et al. Predictors of timely follow-up after abnormal cancer screening among women seeking care at urban community health centers. Cancer 2010;116:913-21.
17. Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J, et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 2010;126:425-33.
18. McPhee SJ, Bird JA, Davis T, Ha NT, Jenkins CN, Le B. Barriers to breast and cervical cancer screening among Vietnamese-American women. Am J Prev Med 1997;13:205-13.
19. Percac-Lima S, Aldrich LS, Gamba GB, Bearse AM, Atlas SJ. Barriers to follow-up of an abnormal Pap smear in Latina women referred for colposcopy. J Gen Intern Med 2010;25:1198-204.
20. Centers for Disease Control and Prevention. National Breast and Cervical Cancer Early Detection Program [homepage on the Internet]. Atlanta, GA: Centers for Disease Control and Prevention; 2011 [cited 2011 Nov 29]. Available from: http://www.cdc.gov/cancer/nbccedp/.
21. Tangka FK, O'Hara B, Gardner JG, Turner J, Royalty J, Shaw K, et al. Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004-2006. Cancer Causes Control 2010;21:1081-90.
22. Centers for Disease Control and Prevention. National and state vaccination coverage among adolescents aged 13 through 17 years-United States, 2010. MMWR Morb Mortal Wkly Rep 2011;60:1117-23.
23. Anhang Price R, Koshiol J, Kobrin S, Tiro JA. Knowledge and intention to participate in cervical cancer screening after the human papillomavirus vaccine. Vaccine 2011;29:4238-43.
24. Caskey R, Lindau ST, Alexander GC. Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health 2009;45:453-62.
25. Cates JR, Brewer NT, Fazekas KI, Mitchell CE, Smith JS. Racial differences in HPV knowledge, HPV vaccine acceptability, and related beliefs among rural, southern women. J Rural Health 2009;25:93-7.
26. Hughes J, Cates JR, Liddon N, Smith JS, Gottlieb SL, Brewer NT. Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiol Biomarkers Prev 2009;18:363-72.
27. Dorell CG, Yankey D, Santibanez TA, Markowitz LE. Human papillomavirus vaccination series initiation and completion, 2008-2009. Pediatrics 2011;128:830-9.
28. Head KJ, Cohen EL. Young women's perspectives on cervical cancer prevention in Appalachian Kentucky. Qual Health Res 2011;22:476-87.
29. Stokley S, Cohn A, Dorell C, Hariri S, Yankey D, Messonnier N, et al. Adolescent vaccination-coverage levels in the United States: 2006-2009. Pediatrics 2011;128:1078-86.
30. Allen JD, Othus MK, Shelton RC, Li Y, Norman N, Tom L, et al. Parental decision making about the HPV vaccine. Cancer Epidemiol Biomarkers Prev 2010;19:2187-98.
31. Katz ML, Reiter PL, Heaner S, Ruffin MT, Post DM, Paskett ED. Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia. Vaccine 2009;27:3945-52.
32. Abdelmutti N, Hoffman-Goetz L. Risk messages about HPV, cervical cancer, and the HPV vaccine Gardasil: a content analysis of Canadian and U.S. national newspaper articles. Women Health 2009;49:422-40.
33. Crosby RA, Casey BR, Vanderpool R, Collins T, Moore GR. Uptake of free HPV vaccination among young women: a comparison of rural versus urban rates. J Rural Health 2011;27:380-4.
34. Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, Glynn S, et al. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Womens Health 2009;18:1679-86.
35. Taylor LD, Hariri S, Sternberg M, Dunne EF, Markowitz LE. Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007-2008. Prev Med 2011;52:398-400.
36. Wong CA, Berkowitz Z, Dorell CG, Price RA, Lee J, Saraiya M. Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008. Cancer 2011;117:5612-20.
37. Vadaparampil ST, Kahn JA, Salmon D, Lee JH, Quinn GP, Roetzheim R, et al. Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine 2011;29:8634-41.
38. Kahn JA, Rosenthal SL, Tissot AM, Bernstein DI, Wetzel C, Zimet GD. Factors influencing pediatricians' intention to recommend human papillomavirus vaccines. Ambul Pediatr 2007;7:367-73.
39. Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices [homepage on the Internet]. Atlanta, GA: Centers for Disease Control and Prevention; 2012 [cited 2012 Mar 27]. Available from: http://www.cdc.gov/vaccines/acip/index.html.
40. Centers for Disease Control and Prevention. Vaccines for Children Program [homepage on the Internet]. Atlanta, GA: Centers for Disease Control and Prevention; 2011 [cited 2012 Mar 27]. Available from: http://www.cdc.gov/ vaccines/programs/vfc/index.html.
41. Giuliano AR. Human papillomavirus vaccination in males. Gynecol Oncol 2007;107:S24-6.
42. Elbasha EH, Dasbach EJ, Insinga RP. Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis 2007;13:28-41.
43. Giuliano AR, Salmon D. The case for a gender-neutral (universal) human papillomavirus vaccination policy in the United States: Point. Cancer Epidemiol Biomarkers Prev 2008;17:805-8.
44. Moyer VA. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012 Mar 14. [Epub ahead of print].
45. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012;137:516-42.
46. Affordable Care Act rules on expanding access to preventive services for women [Internet]. Washington, D.C.: U.S. Department of Health & Human Services; 2012 [cited 2012 Feb 14]. Available from: http://www.healthcare.gov/ news/factsheets/2011/08/womensprevention08012011a.html.
47. Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008;26 Suppl 10:K29-41.
48. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006;119:1095-101.
49. Kitchener HC, Gilham C, Sargent A, Bailey A, Albrow R, Roberts C, et al. A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial. Eur J Cancer 2011;47:864-71.
50. Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, et al. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst 2009;101:1612-23.
51. Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 2011;103:368-83.